Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
108.99
+6.98 (6.84%)
Mar 25, 2026, 11:09 AM EDT - Market open
Celcuity Market Cap
Celcuity has a market cap or net worth of $5.04 billion as of March 25, 2026. Its market cap has increased by 1,227.83% in one year.
Market Cap
5.04B
Enterprise Value
4.83B
1-Year Change
1,227.83%
Ranking
Category
Stock Price
$108.99
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $5.04B, an increase of 3,666.32%. That is a compound annual growth rate of 53.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 4.72B | 2.28% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 5.48B |
| Caris Life Sciences | 5.44B |
| Mirum Pharmaceuticals | 5.40B |
| Xenon Pharmaceuticals | 5.19B |
| Scholar Rock Holding | 5.02B |
| Immunovant | 4.96B |
| TG Therapeutics | 4.86B |
| Amicus Therapeutics | 4.53B |